Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Shares Issued (2019 - 2025)

Eton Pharmaceuticals' Shares Issued history spans 7 years, with the latest figure at $394000.0 for Q1 2025.

  • For Q1 2025, Shares Issued rose 5528.57% year-over-year to $394000.0; the TTM value through Sep 2025 reached $1.4 million, up 3708.11%, while the annual FY2024 figure was $1.2 million, 699.33% up from the prior year.
  • Shares Issued for Q1 2025 was $394000.0 at Eton Pharmaceuticals, down from $1.0 million in the prior quarter.
  • Across five years, Shares Issued topped out at $1.0 million in Q4 2024 and bottomed at -$139000.0 in Q4 2023.
  • The 5-year median for Shares Issued is $103000.0 (2021), against an average of $163066.7.
  • The largest annual shift saw Shares Issued crashed 831.58% in 2023 before it skyrocketed 5528.57% in 2025.
  • A 5-year view of Shares Issued shows it stood at $68000.0 in 2021, then tumbled by 72.06% to $19000.0 in 2022, then plummeted by 831.58% to -$139000.0 in 2023, then surged by 830.22% to $1.0 million in 2024, then plummeted by 61.18% to $394000.0 in 2025.
  • Per Business Quant, the three most recent readings for ETON's Shares Issued are $394000.0 (Q1 2025), $1.0 million (Q4 2024), and $169000.0 (Q2 2024).